{"id":"3-7","rwe":[{"pmid":"41913073","year":"2026","title":"Mapping opioid exposure through prescription data and postmortem analysis of opioid drugs in multiple tissues.","finding":"","journal":"British journal of clinical pharmacology","studyType":"Clinical Study"},{"pmid":"41912508","year":"2026","title":"Expansion of Antarctic surface melt through the 21st century.","finding":"","journal":"Nature communications","studyType":"Clinical Study"},{"pmid":"41912420","year":"2026","title":"Use of Low-Value Cancer Care in Practices Acquired by Private Equity Firms.","finding":"","journal":"Journal of the National Cancer Institute","studyType":"Clinical Study"},{"pmid":"41911655","year":"2026","title":"Hydrological mechanisms and vegetation-soil moisture decoupling in restored alpine grasslands of the Qinghai-Tibet Plateau mining areas.","finding":"","journal":"Journal of environmental management","studyType":"Clinical Study"},{"pmid":"41911506","year":"2026","title":"Directed Evolution of Glutamate Dehydrogenase for Oxaloacetate Amination and Biosynthesis of Aspartate-Derived Chemicals.","finding":"","journal":"ACS synthetic biology","studyType":"Clinical Study"}],"_fda":{"id":"ca7bbcc8-2354-375c-e053-2995a90a72a0","set_id":"0000025c-6dbf-4af7-a741-5cbacaed519a","openfda":{"upc":["8907460005526"],"unii":["ETJ7Z6XBU4"],"route":["ORAL"],"spl_id":["ca7bbcc8-2354-375c-e053-2995a90a72a0"],"brand_name":["SILICEA"],"spl_set_id":["0000025c-6dbf-4af7-a741-5cbacaed519a"],"package_ndc":["15631-0404-0","15631-0404-1","15631-0404-2","15631-0404-3","15631-0404-4","15631-0404-5","15631-0404-6","15631-0404-7"],"product_ndc":["15631-0404"],"generic_name":["SILICEA"],"product_type":["HUMAN OTC DRUG"],"substance_name":["SILICON DIOXIDE"],"manufacturer_name":["Rxhomeo Private Limited d.b.a. Rxhomeo, Inc"],"is_original_packager":[true]},"purpose":["USES USES: Temporary Relief - Acne, Boils* * Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated."],"version":"2","stop_use":["If symptoms do not improve in 4 days, or worsen, discontinue use and seek assistance of health professional."],"warnings":["WARNINGS This product is to be used for self-limiting conditions If symptoms do not improve in 4 days, or worsen, discontinue use and seek assistance of health professional. As with any drug, if you are pregnant, or nursing a baby, seek professional advice before taking this product. Keep this and all medication out of reach of children Do not use if capseal is broken or missing. Close the cap tightly after use."],"questions":["QUESTIONS OR COMMENTS www.Rxhomeo.com | 1.888.2796642 | info@rxhomeo.com Rxhomeo, Inc 3200 Commander Dr, Ste 100-W1, Carrollton, TX 75006 USA"],"do_not_use":["Do not use if capseal is broken or missing. Close the cap tightly after use."],"effective_time":"20210902","active_ingredient":["ACTIVE INGREDIENT SILICEA HPUS 2X and higher"],"inactive_ingredient":["INACTIVE INGREDIENTS Sucrose"],"storage_and_handling":["STORAGE Store in a cool dark place"],"indications_and_usage":["INDICATIONS Condition listed above or as directed by the physician"],"dosage_and_administration":["DOSAGE Adults- Take 4 or 6 Pellets by mouth, three times daily or as suggested by physician. Children 2 years and older- take 1/2 the adult dose."],"spl_product_data_elements":["SILICEA SILICEA SUCROSE SILICON DIOXIDE SILICON DIOXIDE"],"pregnancy_or_breast_feeding":["As with any drug, if you are pregnant, or nursing a baby, seek professional advice before taking this product."],"keep_out_of_reach_of_children":["Keep this and all medication out of reach of children"],"package_label_principal_display_panel":["Mini-Label Label-Pellets Blister-Pack Carton-Pack"]},"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Oral","category":"route"},{"label":"Tablet","category":"form"},{"label":"Active","category":"status"},{"label":"Condition listed above or as directed by the physician","category":"indication"},{"label":"Unique","category":"company"},{"label":"Approved 2010s","category":"decade"}],"phase":"marketed","safety":{"boxedWarnings":[],"safetySignals":[{"date":"","signal":"DRUG INEFFECTIVE","source":"FDA FAERS","actionTaken":"441590 reports"},{"date":"","signal":"OFF LABEL USE","source":"FDA FAERS","actionTaken":"315994 reports"},{"date":"","signal":"NAUSEA","source":"FDA FAERS","actionTaken":"295156 reports"},{"date":"","signal":"FATIGUE","source":"FDA FAERS","actionTaken":"291842 reports"},{"date":"","signal":"DIARRHOEA","source":"FDA FAERS","actionTaken":"253419 reports"},{"date":"","signal":"DYSPNOEA","source":"FDA FAERS","actionTaken":"233258 reports"},{"date":"","signal":"HEADACHE","source":"FDA FAERS","actionTaken":"221781 reports"},{"date":"","signal":"PAIN","source":"FDA FAERS","actionTaken":"202737 reports"},{"date":"","signal":"DIZZINESS","source":"FDA FAERS","actionTaken":"187867 reports"},{"date":"","signal":"VOMITING","source":"FDA FAERS","actionTaken":"187544 reports"}]},"trials":[],"aliases":["IA or DA"],"company":"Unique","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=\"3+7\"","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T01:09:16.448988+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T01:09:22.067570+00:00"},"regulatory.us":{"url":"","method":"api_direct","source":"FDA Drugs@FDA","rawText":"","confidence":1,"sourceType":"fda_drugsfda","retrievedAt":"2026-04-20T01:09:15.515392+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=\"3+7\"","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T01:09:22.490248+00:00"},"administration.route":{"url":"","method":"deterministic","source":"FDA Label","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T01:09:10.766325+00:00"},"safety.boxedWarnings":{"url":"","method":"deterministic","source":"FDA Label (no boxed warning)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T01:09:10.766356+00:00"},"safety.safetySignals":{"url":"https://api.fda.gov/drug/event.json","method":"api_direct","source":"FDA FAERS","rawText":"","confidence":1,"sourceType":"fda_faers","retrievedAt":"2026-04-20T01:09:25.514294+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Cytochrome P450 51 inhibitor","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:09:23.956530+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL91/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:09:23.619470+00:00"}},"allNames":"silicea","offLabel":[],"synonyms":["Silicea","SILICON DIOXIDE"],"timeline":[{"date":"20130909","type":"positive","source":"OpenFDA","milestone":"FDA approval (Unique)"}],"approvals":[{"date":"20130909","orphan":false,"company":"UNIQUE","regulator":"FDA"}],"brandName":"Silicea","ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"","oneSentence":"","technicalDetail":"Silicea is a small molecule that binds to a specific receptor, triggering a cascade of downstream effects that ultimately lead to the regulation of the target biological pathway."},"commercial":{"launchDate":"2013","_launchSource":"OpenFDA (20130909, UNIQUE)"},"references":[{"id":1,"url":"https://api.fda.gov/drug/label.json?search=openfda.generic_name:\"\"3+7\"\"","fields":["mechanism","indications","adverse_reactions","contraindications","warnings","dosage"],"source":"OpenFDA Label"},{"id":2,"url":"https://api.fda.gov/drug/drugsfda.json?search=openfda.generic_name:\"\"3+7\"\"","fields":["approvals","company"],"source":"OpenFDA Drugs@FDA"},{"id":3,"url":"https://clinicaltrials.gov/search?intr=%223%2B7%22","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":4,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=\"3+7\"","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-31T10:32:29.971816","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:09:26.976094+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[],"genericName":"\"3+7\"","indications":{"approved":[{"name":"Condition listed above or as directed by the physician","source":"OpenFDA Label","regulator":"FDA","eligibility":"Known indications"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT04729959","phase":"PHASE2","title":"Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent Glioblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2022-03-11","conditions":["Diffuse Astrocytoma, IDH-Wildtype","Recurrent Glioblastoma"],"enrollment":59,"completionDate":"2026-09-04"},{"nctId":"NCT07500207","phase":"PHASE3","title":"A Phase III Clinical Trial on Immunogenicity and Safety of Lyophilized Rabies Vaccine for Human Use (Human Diploid Cell)","status":"ENROLLING_BY_INVITATION","sponsor":"Changchun BCHT Biotechnology Co.","startDate":"2026-03-04","conditions":["Rabies Prevention"],"enrollment":3000,"completionDate":"2027-03-25"},{"nctId":"NCT03289910","phase":"PHASE2","title":"Topotecan Hydrochloride and Carboplatin With or Without Veliparib in Treating Advanced Myeloproliferative Disorders and Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2018-09-24","conditions":["Acute Myeloid Leukemia","Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome","Atypical Chronic Myeloid Leukemia","Chronic Myelomonocytic Leukemia","Essential Thrombocythemia","Myelodysplastic/Myeloproliferative Neoplasm","Myelofibrosis","Polycythemia Vera","Recurrent Acute Myeloid Leukemia","Refractory Acute Myeloid Leukemia"],"enrollment":25,"completionDate":"2026-12-18"},{"nctId":"NCT07148089","phase":"PHASE1","title":"A Study of SGT-501 Gene Therapy in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)","status":"RECRUITING","sponsor":"Solid Biosciences Inc.","startDate":"2026-02-23","conditions":["Catecholaminergic Polymorphic Ventricular Tachycardia"],"enrollment":18,"completionDate":"2031-05"},{"nctId":"NCT07407140","phase":"PHASE3","title":"VAG Versus Standard Chemotherapy With FLT3 Inhibitor in Adult Patients With FLT3-Mutated AML","status":"NOT_YET_RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2026-04-30","conditions":["AML, Adult"],"enrollment":300,"completionDate":"2030-12-31"},{"nctId":"NCT06313437","phase":"PHASE1","title":"Revumenib in Combination With 7+3 + Midostaurin in AML","status":"RECRUITING","sponsor":"Richard Stone, MD","startDate":"2024-12-06","conditions":["Acute Myeloid Leukemia","AML, Adult","AML With Gene Mutations","AML","Leukemia"],"enrollment":22,"completionDate":"2028-03-02"},{"nctId":"NCT05658003","phase":"PHASE2","title":"A Study Evaluating [177Lu]Lu-PSMA-617 vs. a Change of Androgen Receptor-directed Therapy in Taxane Treatment Naive Chinese Male Patients With Progressive Metastatic Castrate Resistant Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2023-05-05","conditions":["Metastatic Castration-Resistant Prostate Cancer (mCRPC)"],"enrollment":63,"completionDate":"2027-01-13"},{"nctId":"NCT07486479","phase":"PHASE3","title":"Venetoclax, Azacitidine, and Mitoxantrone Hydrochloride Liposome Versus Idarubicin and Cytarabine in Newly Diagnosed AML","status":"NOT_YET_RECRUITING","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2026-03-10","conditions":["Acute Myeloid Leukemia (AML)"],"enrollment":204,"completionDate":"2027-12-31"},{"nctId":"NCT06928376","phase":"PHASE2","title":"A Multicenter RCT of \"3+7\" vs Venetoclax + CACAG in Newly Diagnosed Mid/High-Risk AML Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Chinese PLA General Hospital","startDate":"2024-04-18","conditions":["Acute Myeloid Leukemia","First Line Therapy"],"enrollment":160,"completionDate":"2026-09-01"},{"nctId":"NCT03275584","phase":"PHASE4","title":"Safety of PET MPI Using the CRCHUM N-13 Ammonia","status":"RECRUITING","sponsor":"Centre hospitalier de l'Université de Montréal (CHUM)","startDate":"2018-01-30","conditions":["N-13 Ammonia Safety"],"enrollment":20000,"completionDate":"2028-01"},{"nctId":"NCT05783596","phase":"PHASE2","title":"Glofit and Obin in Follicular Lymphoma and Marginal Zone Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Reid Merryman, MD","startDate":"2023-07-18","conditions":["Follicular Lymphoma","Marginal Zone Lymphoma","Indolent Non-hodgkin Lymphoma"],"enrollment":47,"completionDate":"2029-08"},{"nctId":"NCT05114746","phase":"PHASE2","title":"Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer in Japan","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2022-01-25","conditions":["Prostate Cancer"],"enrollment":87,"completionDate":"2026-06-25"},{"nctId":"NCT05081999","phase":"PHASE4","title":"De-Adoption of Beta-Blockers in Patients With Stable Ischemic Heart Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Alberta","startDate":"2023-01-30","conditions":["Stable Ischemic Heart Disease","Coronary Artery Disease","Beta-blocker Therapy"],"enrollment":59,"completionDate":"2026-12-31"},{"nctId":"NCT07466966","phase":"NA","title":"Minimally-Invasive Non-Surgical Therapy of Peri-Implantitis","status":"RECRUITING","sponsor":"St. Anne's University Hospital Brno, Czech Republic","startDate":"2026-01-01","conditions":["Peri-implantitis","Periodontitis","Non-surgical Periodontal Therapy"],"enrollment":106,"completionDate":"2028-04"},{"nctId":"NCT07466641","phase":"NA","title":"LLLLT vs Piezocision in Accelerating Orthodontic Canine Retraction","status":"NOT_YET_RECRUITING","sponsor":"Hesham Nabil Ali Al-Qamhawy","startDate":"2026-04","conditions":["Malocclusion, Angle Class II, Division 1","Bimaxillary Protrusion","Class I Malocclusion"],"enrollment":21,"completionDate":"2027-06"},{"nctId":"NCT07335484","phase":"NA","title":"Aquarius Pilot Study to Evaluate the New Axonics Trial System","status":"NOT_YET_RECRUITING","sponsor":"Axonics, Inc.","startDate":"2026-04","conditions":["Urinary Urge Incontinence (UUI)","Urinary Frequency (UF)","Fecal Incontinence (FI)","Overactive Bladder (OAB)"],"enrollment":75,"completionDate":"2026-12"},{"nctId":"NCT05877300","phase":"PHASE1","title":"Safety and Feasibility Study of the CELLSPAN Esophageal Implant (CEI) in Patients Requiring Short Segment Esophageal Replacement","status":"RECRUITING","sponsor":"Harvard Apparatus Regenerative Technology, Inc.","startDate":"2023-07-13","conditions":["Esophageal Diseases"],"enrollment":10,"completionDate":"2026-12"},{"nctId":"NCT03226418","phase":"PHASE2","title":"Geriatric Assessment & Genetic Profiling to Personalize Therapy in Older Adults With Acute Myeloid Leukemia","status":"COMPLETED","sponsor":"University of Nebraska","startDate":"2017-07-07","conditions":["Adult Acute Myeloid Leukemia","Secondary Acute Myeloid Leukemia","Therapy-Related Acute Myeloid Leukemia"],"enrollment":75,"completionDate":"2024-10-01"},{"nctId":"NCT07173166","phase":"NA","title":"Non-Pharmacological Interventions for Neurotoxicity in Hematologic Patients Receiving CAR-T Therapy","status":"RECRUITING","sponsor":"Instituto de Investigacion Sanitaria INCLIVA","startDate":"2025-09-30","conditions":["Hematologic Cancer"],"enrollment":100,"completionDate":"2028-09"},{"nctId":"NCT06713837","phase":"PHASE3","title":"IMPACT-AML: A Randomized Pragmatic Clinical Trial for Relapsed or Refractory Acute Myeloid Leukemia.","status":"RECRUITING","sponsor":"Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS","startDate":"2025-02-27","conditions":["Acute Myeloid Leukemia","Relapse/Recurrence"],"enrollment":339,"completionDate":"2028-01"},{"nctId":"NCT06401330","phase":"PHASE3","title":"A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)","status":"RECRUITING","sponsor":"Children's Oncology Group","startDate":"2025-04-15","conditions":["Stage I Mixed Cell Type Kidney Wilms Tumor","Stage II Mixed Cell Type Kidney Wilms Tumor","Stage III Mixed Cell Type Kidney Wilms Tumor","Stage IV Mixed Cell Type Kidney Wilms Tumor"],"enrollment":1656,"completionDate":"2031-02-13"},{"nctId":"NCT07205939","phase":"NA","title":"Evaluation of Surgical Site Infection After Cesarean Section","status":"COMPLETED","sponsor":"Sibel Bulut Haklı","startDate":"2025-01-05","conditions":["Surgical Infection","Cesarean Section Wound"],"enrollment":216,"completionDate":"2026-02-05"},{"nctId":"NCT07445815","phase":"PHASE2","title":"A Phase II Trial of a Recombinant Human Anti-Rabies Virus Monoclonal Antibody","status":"NOT_YET_RECRUITING","sponsor":"Lanzhou Institute of Biological Products Co., Ltd","startDate":"2026-01-31","conditions":["Rabies (Healthy Volunteers)"],"enrollment":200,"completionDate":"2026-08-21"},{"nctId":"NCT07283094","phase":"PHASE1","title":"FHD-286 With Low-Dose Weekly Decitabine/Venetoclax in Patients With Acute Myeloid Leukemia","status":"RECRUITING","sponsor":"Montefiore Medical Center","startDate":"2026-02-03","conditions":["Acute Myeloid Leukemia","Myelodysplastic Syndrome"],"enrollment":33,"completionDate":"2030-02"},{"nctId":"NCT07442825","phase":"NA","title":"Evaluating Laser and Piezocision vs. Piezocision Alone on Root Resorption and Gingival Health During Tooth Retraction","status":"COMPLETED","sponsor":"Damascus University","startDate":"2023-05-06","conditions":["Malocclusion, Angle Class II, Division 1"],"enrollment":66,"completionDate":"2025-03-18"},{"nctId":"NCT07439120","phase":"EARLY_PHASE1","title":"Safety and Tolerability Study of 68Ga/177Lu-BRP-020063 in Advanced Solid Tumors","status":"NOT_YET_RECRUITING","sponsor":"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","startDate":"2026-03-02","conditions":["Urothelial Carcinoma (UC)"],"enrollment":10,"completionDate":"2026-08-31"},{"nctId":"NCT06791434","phase":"PHASE4","title":"Assessing the Benefits of Dry Needling for Low Back Pain When Combined With Regular Treatment","status":"COMPLETED","sponsor":"Dr. Vishwanath Karad MIT World Peace University","startDate":"2024-08-30","conditions":["Low Back Pain"],"enrollment":156,"completionDate":"2025-08-26"},{"nctId":"NCT07425990","phase":"NA","title":"FET-LET-2x2: Clinical Pregnancy Rates After Frozen Embryo Transfer in Natural and Modified Natural Cycles","status":"NOT_YET_RECRUITING","sponsor":"University of Novi Sad","startDate":"2026-02","conditions":["Infertility Female","Frozen Embryo Transfer (FET)"],"enrollment":120,"completionDate":"2027-03"},{"nctId":"NCT03686007","phase":"NA","title":"Multimedia Self-Management Intervention for Lung Cancer Surgery Family Caregivers and Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2018-11-06","conditions":["Caregiver","Stage I Lung Cancer AJCC v7","Stage IA Lung Cancer AJCC v7","Stage IB Lung Cancer AJCC v7","Stage II Lung Cancer AJCC v7","Stage IIA Lung Cancer AJCC v7","Stage IIB Lung Cancer AJCC v7","Stage III Lung Cancer AJCC v7","Stage IIIA Lung Cancer AJCC v7","Stage IIIB Lung Cancer AJCC v7"],"enrollment":380,"completionDate":"2026-12-14"},{"nctId":"NCT02339740","phase":"PHASE3","title":"Tretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2015-07-21","conditions":["Acute Promyelocytic Leukemia With t(15;17)(q24.1;q21.2); PML-RARA"],"enrollment":158,"completionDate":"2029-06-30"},{"nctId":"NCT07413705","phase":"NA","title":"BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Sexual Function Among Perimenopausal and Postmenopausal Women","status":"RECRUITING","sponsor":"BTL Industries Ltd.","startDate":"2025-11-20","conditions":["Depressive Symptoms","Urinary Incontinence","Sexual Dysfunction"],"enrollment":60,"completionDate":"2026-12-11"},{"nctId":"NCT07413692","phase":"NA","title":"BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Urinary Incontinence in Postpartum and Early Post-Childbirth Women","status":"RECRUITING","sponsor":"BTL Industries Ltd.","startDate":"2025-11-25","conditions":["Depressive Symptoms","Urinary Incontinence"],"enrollment":60,"completionDate":"2026-12-11"},{"nctId":"NCT07000461","phase":"","title":"Transcranial Doppler as a Predictor of Postoperative Cognitive Dysfunction Following Cardiopulmonary Bypass","status":"RECRUITING","sponsor":"Bakirkoy Dr. Sadi Konuk Research and Training Hospital","startDate":"2025-04-17","conditions":["Postoperative Cognitive Dysfunction","Delirium, Postoperative"],"enrollment":106,"completionDate":"2026-04-30"},{"nctId":"NCT04919369","phase":"PHASE1","title":"All-Trans Retinoic Acid (ATRA) and Atezolizumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Dwight Owen","startDate":"2021-10-18","conditions":["Metastatic Lung Non-Small Cell Carcinoma","Recurrent Lung Non-Small Cell Carcinoma","Stage IV Lung Cancer AJCC v8","Stage IVA Lung Cancer AJCC v8","Stage IVB Lung Cancer AJCC v8"],"enrollment":18,"completionDate":"2026-12-31"},{"nctId":"NCT05670106","phase":"PHASE2","title":"A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Dosimetry of [177Lu]Lu-PSMA-617 in Chinese Adult Male Patients With Progressive PSMA-Positive mCRPC","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2023-05-16","conditions":["Metastatic Castration-Resistant Prostate Cancer (mCRPC)"],"enrollment":62,"completionDate":"2026-06-30"},{"nctId":"NCT06325748","phase":"PHASE1","title":"SENTI-202: Off-the-shelf Logic Gated CAR NK Cell Therapy in Adults With CD33 and/or FLT3 Blood Cancers Including AML/MDS","status":"ACTIVE_NOT_RECRUITING","sponsor":"Senti Biosciences","startDate":"2024-04-22","conditions":["AML/MDS","CD33 Expressing Hematological Malignancies","FLT3 Expressing Hematological Malignancies"],"enrollment":21,"completionDate":"2040-08"},{"nctId":"NCT07057999","phase":"NA","title":"Investigation of the Effect of the MIND Diet on Disease Symptoms in Patients With MS","status":"COMPLETED","sponsor":"Betul Uner","startDate":"2025-06-16","conditions":["Multiple Sclerosis","Diet Therapy","Body Composition","Randomised Controlled Trial","Brain Fog","Fatigue Syndrome, Chronic","Quality of Life (QOL)"],"enrollment":62,"completionDate":"2025-12-27"},{"nctId":"NCT06164678","phase":"NA","title":"Vaping Cessation Using the Ottawa Model for Smoking Cessation Among E-Cigarette Users","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ottawa Heart Institute Research Corporation","startDate":"2024-07-11","conditions":["Tobacco Smoking","Vaping"],"enrollment":180,"completionDate":"2026-12"},{"nctId":"NCT07386808","phase":"NA","title":"Improvement of Sleep Disorders in Patients With Alzheimer's Disease After Sunlight Exposure Therapy.","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Taiwan University Hospital","startDate":"2026-01-09","conditions":["Alzheimer's Disease (AD)","Sleep Disorders, Circadian Rhythm"],"enrollment":60,"completionDate":"2026-12-31"},{"nctId":"NCT07372404","phase":"NA","title":"Allogeneic Adipose Tissue Extract in Wound Treatment and Scar Maturation","status":"RECRUITING","sponsor":"Linio Biotech Oy","startDate":"2023-04-11","conditions":["Wound Healing"],"enrollment":30,"completionDate":"2026-12-31"},{"nctId":"NCT07021352","phase":"NA","title":"Auricular Acupuncture on Emotional Distress in Service Members and Veterans With PTSD","status":"NOT_YET_RECRUITING","sponsor":"United States Naval Medical Center, San Diego","startDate":"2026-02","conditions":["PTSD and Substance Use Disorder","Emotional Distress"],"enrollment":66,"completionDate":"2028-06"},{"nctId":"NCT05455294","phase":"PHASE1","title":"Combination Navitoclax, Venetoclax and Decitabine for Advanced Myeloid Neoplasms","status":"ACTIVE_NOT_RECRUITING","sponsor":"Jacqueline Garcia, MD","startDate":"2022-07-18","conditions":["Myeloid Malignancy","Myelodysplastic Syndromes","Myelofibrosis","Acute Myeloid Leukemia","Myeloproliferative Neoplasm"],"enrollment":16,"completionDate":"2026-12-31"},{"nctId":"NCT07369219","phase":"NA","title":"Effect of a Nursing Care Intervention on Outcomes of Stoma Patients Within an Enhanced Recovery Framework","status":"ACTIVE_NOT_RECRUITING","sponsor":"Bahçeşehir University","startDate":"2025-05-20","conditions":["Home Care","Stoma","Enhanced Recovery"],"enrollment":98,"completionDate":"2026-12-30"},{"nctId":"NCT01231906","phase":"PHASE3","title":"Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2010-11-24","conditions":["Localized Extraskeletal Ewing Sarcoma","Peripheral Primitive Neuroectodermal Tumor of Bone","Peripheral Primitive Neuroectodermal Tumor of Soft Tissues"],"enrollment":642,"completionDate":"2025-12-31"},{"nctId":"NCT06068621","phase":"PHASE2","title":"Venetoclax Plus CACAG Regimen for Newly Diagnosed Acute Myeloid Leukemia","status":"COMPLETED","sponsor":"Chinese PLA General Hospital","startDate":"2023-03-01","conditions":["Acute Myeloid Leukemia"],"enrollment":200,"completionDate":"2025-08-31"},{"nctId":"NCT02087826","phase":"NA","title":"Study of Clinical Response to Acute Metformin By Leveraging Evaluations During a Mixed Meal Tolerance Test for Exploring Glycemia and GeneticS","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2014-04","conditions":["Genetics","Metabolism","Type 2 Diabetes"],"enrollment":1017,"completionDate":"2026-12"},{"nctId":"NCT07342257","phase":"PHASE1","title":"SYN023 With Rabies Vaccine in Healthy Pediatric Subjects","status":"COMPLETED","sponsor":"Synermore Biologics (Suzhou) Co., Ltd.","startDate":"2024-11-30","conditions":["Rabies Post-exposure Prophylaxis"],"enrollment":108,"completionDate":"2025-07-23"},{"nctId":"NCT07330661","phase":"NA","title":"Nursing-Led Deep Vein Thrombosis Prevention in Neurosurgery","status":"COMPLETED","sponsor":"West China Hospital","startDate":"2021-01-01","conditions":["Deep Vein Thrombosis (DVT)"],"enrollment":1286,"completionDate":"2024-05-01"},{"nctId":"NCT07329738","phase":"NA","title":"Single-Subject Research Design on 3D-Printed Prosthetic Sockets","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of British Columbia","startDate":"2023-07-17","conditions":["Transtibial Amputees"],"enrollment":8,"completionDate":"2026-03-11"},{"nctId":"NCT07326761","phase":"NA","title":"Microplastic Exposure in Neonates Receiving Parenteral Nutrition: A Prospective Cohort Study in the NICU","status":"COMPLETED","sponsor":"Huiyi Li","startDate":"2025-01-01","conditions":["Microplastics Exposure"],"enrollment":12,"completionDate":"2025-11-01"},{"nctId":"NCT06558214","phase":"PHASE2","title":"OPTIMUS PRIME: Safety and Feasibility of OPTune GIO® Integrated With MRI-gUided Laser Ablation Surgery and Pembrolizumab for Recurrent GlIoblastoMa, A randomizEd Trial","status":"RECRUITING","sponsor":"University of Florida","startDate":"2024-12-10","conditions":["Recurrent Glioblastoma"],"enrollment":20,"completionDate":"2029-10"},{"nctId":"NCT07051655","phase":"NA","title":"The Effects of Exogenous Ketones on Cognitive Function","status":"RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2025-12-01","conditions":["Placebo - Control","Ketone Monoester"],"enrollment":45,"completionDate":"2026-04"},{"nctId":"NCT07318831","phase":"PHASE2","title":"Phase II Study of Chidamide-Dinutuximab Beta-Irinotecan-Temozolomide for Refractory/Relapsed Neuroblastoma in Children","status":"NOT_YET_RECRUITING","sponsor":"Tianjin Medical University Cancer Institute and Hospital","startDate":"2025-12-31","conditions":["Neuroblastoma (NB)","Neuroblastoma in Children"],"enrollment":27,"completionDate":"2028-12-31"},{"nctId":"NCT06132789","phase":"PHASE1","title":"A Clinical Trial of Rabies Vaccine（Human Diploid Cell）for Human Use,Freeze-dried in a Population Aged 10-60 Years","status":"COMPLETED","sponsor":"Ab&B Bio-tech Co., Ltd.JS","startDate":"2023-11-27","conditions":["Rabies"],"enrollment":80,"completionDate":"2024-08-16"},{"nctId":"NCT07313020","phase":"EARLY_PHASE1","title":"Handheld MPI Imaging to Track Stem Cells in Osteoarthritis","status":"ENROLLING_BY_INVITATION","sponsor":"Soochow University","startDate":"2025-12-16","conditions":["Knee Arthritis Osteoarthritis"],"enrollment":10,"completionDate":"2026-12-16"},{"nctId":"NCT07205354","phase":"","title":"Design of a Food Preference Assessment Tool for Older Patients in Geriatrics units_DYSPHAGING-PREFERENCES","status":"RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2025-10-10","conditions":["Hospitalisation in Geriatrics","Swallowing Disorder","Eating Habits"],"enrollment":209,"completionDate":"2027-02-10"},{"nctId":"NCT07275645","phase":"PHASE3","title":"A Clinical Trial of Rabies Vaccine（Human Diploid Cell）for Human Use,Freeze-dried in a Population Aged 10 to 60 Years","status":"NOT_YET_RECRUITING","sponsor":"Ab&B Bio-tech Co., Ltd.JS","startDate":"2025-12-18","conditions":["Rabies"],"enrollment":3000,"completionDate":"2027-02-18"},{"nctId":"NCT01409161","phase":"PHASE2","title":"Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2011-10-05","conditions":["Acute Promyelocytic Leukemia With PML-RARA"],"enrollment":151,"completionDate":"2027-12-18"},{"nctId":"NCT03013998","phase":"PHASE1,PHASE2","title":"Study of Biomarker-Based Treatment of Acute Myeloid Leukemia","status":"RECRUITING","sponsor":"Beat AML, LLC","startDate":"2016-11","conditions":["Previously Untreated Relapsed Refractory Acute Myeloid Leukemia"],"enrollment":3000,"completionDate":"2028-12"},{"nctId":"NCT05919823","phase":"PHASE3","title":"A Study to Assess the Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Chinese Adult Subjects With DSM-5 Schizophrenia","status":"COMPLETED","sponsor":"Karuna Therapeutics, Inc., a Bristol Myers Squibb company","startDate":"2023-05-29","conditions":["Schizophrenia"],"enrollment":202,"completionDate":"2024-12-09"},{"nctId":"NCT02699697","phase":"NA","title":"Palliative Radiation Therapy in Reducing Pain in Patients With Bone Metastasis","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2016-05","conditions":["Malignant Neoplasm","Metastatic Malignant Neoplasm in the Bone","Pain"],"enrollment":102,"completionDate":"2025-03-20"},{"nctId":"NCT05416138","phase":"NA","title":"Theta Phase-specific TMS to Modulate Prefrontal Activity","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2022-11-01","conditions":["Approach/Avoidance Behavior"],"enrollment":26,"completionDate":"2024-08-31"},{"nctId":"NCT07056036","phase":"NA","title":"EXOMIND (BTL-699-2) for the Improvement in Willpower & Food Cravings","status":"COMPLETED","sponsor":"BTL Industries Ltd.","startDate":"2024-11-01","conditions":["Self-Control","Food Cravings"],"enrollment":51,"completionDate":"2025-10-10"},{"nctId":"NCT05663216","phase":"","title":"Determinants of Vascular Leakage During Systemic Inflammatory Response Syndrome","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-05-31","conditions":["Systemic Inflammatory Response Syndrome"],"enrollment":180,"completionDate":"2028-07-01"},{"nctId":"NCT05922618","phase":"NA","title":"Pulsed Electromagnetic Fields (PEMFS) in Complex Regional Pain Syndrome Type i (CRPS-I) of the Foot (PeCFoA)","status":"RECRUITING","sponsor":"Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari","startDate":"2023-08-01","conditions":["Pain, Joint","Complex Regional Pain Syndromes","Ankle Disease","Foot Diseases"],"enrollment":28,"completionDate":"2025-12-01"},{"nctId":"NCT05990946","phase":"NA","title":"Smartphone-based Remote Symptom Monitoring to Improve Postoperative Rehabilitation Exercise Adherence After Video-assisted Thoracic Surgery (VATS) for Lung Cancer","status":"RECRUITING","sponsor":"Zhongshan People's Hospital, Guangdong, China","startDate":"2023-06-01","conditions":["Lung Neoplasms, Non-Small Cell Lung Cancer","Postoperative Complications","Patient Reported Outcome Measures","Telerehabilitation","Exercise Therapy"],"enrollment":736,"completionDate":"2026-06-30"},{"nctId":"NCT05816070","phase":"PHASE2","title":"Trial to Evaluate the Efficacy and Safety of IVIEW-1201 in Acute Bacterial Conjunctivitis","status":"COMPLETED","sponsor":"IVIEW Therapeutics Inc.","startDate":"2023-01-05","conditions":["Acute Bacterial Conjunctivitis"],"enrollment":129,"completionDate":"2024-10-12"},{"nctId":"NCT02048813","phase":"PHASE3","title":"Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2014-03-10","conditions":["Anemia","Chronic Lymphocytic Leukemia","Small Lymphocytic Lymphoma"],"enrollment":529,"completionDate":"2026-10-09"},{"nctId":"NCT07253207","phase":"PHASE3","title":"Efficacy and Safety Study of Levomilnacipran Hydrochloride Extended-Release Capsules in Major Depressive Disorder","status":"COMPLETED","sponsor":"Zhejiang Huahai Pharmaceutical Co., Ltd.","startDate":"2024-10-17","conditions":["Major Depressive Disorder (MDD)"],"enrollment":392,"completionDate":"2025-07-22"},{"nctId":"NCT07248683","phase":"NA","title":"Application of Intermittent Training in Radial Artery Puncture and Catheterization Skills Under Ultrasound-Guided Line Guidance","status":"NOT_YET_RECRUITING","sponsor":"General Hospital of Ningxia Medical University","startDate":"2025-11-20","conditions":["Learning and Memorization of Radial Artery Puncture and Catheterization Guided by Ultrasound Midline"],"enrollment":30,"completionDate":"2026-02-28"},{"nctId":"NCT03011528","phase":"PHASE2","title":"First-line Treatment of Ewing Tumours With Primary Extrapulmonary Dissemination in Patients From 2 to 50 Years (CombinaiR3)","status":"COMPLETED","sponsor":"Institut Curie","startDate":"2016-12","conditions":["Ewing Sarcoma Family of Tumors"],"enrollment":45,"completionDate":"2023-11"},{"nctId":"NCT07240077","phase":"PHASE4","title":"Beta-lactam Plus Levofloxacin to Enhance Therapy in Streptococcal Septicemia","status":"NOT_YET_RECRUITING","sponsor":"Mahidol University","startDate":"2026-01-01","conditions":["Bacteremia","Streptococcus Infection"],"enrollment":165,"completionDate":"2028-12-31"},{"nctId":"NCT06944275","phase":"","title":"Characterising the Loss of Haemostasis in Haemorrhagic Fever With Renal Syndrome","status":"NOT_YET_RECRUITING","sponsor":"Liverpool School of Tropical Medicine","startDate":"2026-05-01","conditions":["Haemorrhagic Fever With Renal Syndrome"],"enrollment":62,"completionDate":"2027-08-31"},{"nctId":"NCT05424354","phase":"PHASE4","title":"Acute Partial Thickness Burn Study Comparing Transforming Powder Dressing to Standard of Care Dressing","status":"RECRUITING","sponsor":"ULURU Inc.","startDate":"2022-05-26","conditions":["Wounds and Injuries"],"enrollment":60,"completionDate":"2026-09-30"},{"nctId":"NCT06206707","phase":"NA","title":"FMT in Checkpoint Inhibitor-mediated Diarrhea and Colitis","status":"RECRUITING","sponsor":"University of Aarhus","startDate":"2024-01-23","conditions":["Diarrhea","Colitis","Malignant Melanoma","Kidney Cancer"],"enrollment":20,"completionDate":"2026-10-31"},{"nctId":"NCT06451861","phase":"PHASE2","title":"Randomized Study of ABC-14 Regimen Compared With \"3+7\" Standard Induction Therapy or AB-14 for ND AML","status":"RECRUITING","sponsor":"Guangdong Provincial People's Hospital","startDate":"2024-08-21","conditions":["Acute Myeloid Leukemia"],"enrollment":240,"completionDate":"2027-06-30"},{"nctId":"NCT06320535","phase":"PHASE1","title":"A Phase 1 Study to Assess an Escalating Dose, Multi-prime Vaccination Schedule of R21/Matrix-M™","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Oxford","startDate":"2024-03-25","conditions":["Malaria,Falciparum"],"enrollment":36,"completionDate":"2027-06"},{"nctId":"NCT03187951","phase":"NA","title":"PancFit: Multimodal Exercise During Preoperative Therapy for Pancreatic Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2017-06-13","conditions":["Other Disorders of Glucose Regulation and Pancreatic Internal Secretion","Pancreatic Cancer"],"enrollment":152,"completionDate":"2026-12-31"},{"nctId":"NCT06315309","phase":"PHASE2","title":"Trial of 2 Step ATG for Acute GVHD Prevention Post Myeloablative Allogeneic Stem Cell Transplant","status":"RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2025-04-15","conditions":["GVHD,Acute","Acute Leukemia","Myelodysplastic Syndromes","Myeloproliferative Disorders"],"enrollment":29,"completionDate":"2027-05"},{"nctId":"NCT06265584","phase":"PHASE2","title":"Trial of 2 Step ATG for Prevention of Acute GVHD Post Allogeneic Stem Cell Transplant","status":"RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2025-04-08","conditions":["Acute Leukemia","Myelodysplastic Syndrome","Myeloproliferative Disorders"],"enrollment":56,"completionDate":"2028-11"},{"nctId":"NCT04637984","phase":"NA","title":"The Implementation of PREP2 Algorithm Into Clinical Practice","status":"COMPLETED","sponsor":"University Hospital of Ferrara","startDate":"2019-05-27","conditions":["Stroke","Rehabilitation"],"enrollment":200,"completionDate":"2022-12-20"},{"nctId":"NCT04777916","phase":"","title":"Prospective Non-interventional Study of Adult Patients With Acute Myeloid Leukemia (AML)","status":"RECRUITING","sponsor":"Acute Leukemia French Association","startDate":"2022-04-14","conditions":["Acute Myeloid Leukemia (AML)"],"enrollment":5000,"completionDate":"2046-04-01"},{"nctId":"NCT06710483","phase":"NA","title":"A Pilot Project to Facilitate Dental Care and Reduce Barriers For Youth With Disabilities","status":"RECRUITING","sponsor":"Boston University","startDate":"2025-08-20","conditions":["Intellectual Disability, Variable"],"enrollment":50,"completionDate":"2026-06"},{"nctId":"NCT02537613","phase":"PHASE1","title":"A Study of Ibrutinib + Obinutuzumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Dana-Farber Cancer Institute","startDate":"2015-12","conditions":["Chronic Lymphocytic Leukemia"],"enrollment":54,"completionDate":"2027-01"},{"nctId":"NCT04362189","phase":"PHASE2","title":"Efficacy and Safety Study of Allogeneic HB-adMSCs for the Treatment of COVID-19","status":"TERMINATED","sponsor":"Hope Biosciences Research Foundation","startDate":"2020-06-30","conditions":["COVID-19"],"enrollment":48,"completionDate":"2021-09-30"},{"nctId":"NCT04917861","phase":"PHASE2","title":"A Study of Zika Vaccine mRNA-1893 in Adult Participants Living in Endemic and Non-Endemic Flavivirus Areas","status":"COMPLETED","sponsor":"ModernaTX, Inc.","startDate":"2021-06-07","conditions":["Zika Virus"],"enrollment":808,"completionDate":"2024-07-26"},{"nctId":"NCT05926661","phase":"NA","title":"Support Tool for Families of High-Risk Children With Heart Disease During Hospital Admission and After Discharge","status":"WITHDRAWN","sponsor":"Nemours Children's Clinic","startDate":"2023-11-29","conditions":["Heart Disease Congenital"],"enrollment":0,"completionDate":"2024-04-30"},{"nctId":"NCT07182734","phase":"NA","title":"Feasibility of Unsupervised Therapy After Neurological or Orthopaedical Injury in the Home Setting With a Hand Rehabilitation Device (ReHandyBot) and an Assistive Smartphone Application (RehabCoach)","status":"NOT_YET_RECRUITING","sponsor":"Swiss Federal Institute of Technology","startDate":"2025-09-15","conditions":["Rehabilitation After Neurological or Orthopaedic Injuries"],"enrollment":30,"completionDate":"2028-08-01"},{"nctId":"NCT03965962","phase":"PHASE3","title":"Study of Purified Vero Rabies Vaccine Compared With Two Reference Rabies Vaccines in a Simulated Post-Exposure Regimen in Adults","status":"COMPLETED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2019-07-01","conditions":["Rabies (Healthy Volunteers)"],"enrollment":640,"completionDate":"2021-07-01"},{"nctId":"NCT04820309","phase":"PHASE3","title":"An Open-label Study to Assess the Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-5)","status":"COMPLETED","sponsor":"Karuna Therapeutics, Inc., a Bristol Myers Squibb company","startDate":"2021-06-02","conditions":["Schizophrenia"],"enrollment":566,"completionDate":"2024-05-24"},{"nctId":"NCT06268171","phase":"","title":"Ultrasound Assessment of Rectus Femoris Cross-sectionnal Area Following Lung Transplantation","status":"COMPLETED","sponsor":"Hopital Foch","startDate":"2024-03-27","conditions":["Lung Transplant","Physiotherapy","Sarcopenia"],"enrollment":42,"completionDate":"2025-05-27"},{"nctId":"NCT00972478","phase":"PHASE1,PHASE2","title":"Vorinostat, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2010-11-15","conditions":["Ann Arbor Stage II Non-Hodgkin Lymphoma","Ann Arbor Stage III Non-Hodgkin Lymphoma","Ann Arbor Stage IV Non-Hodgkin Lymphoma"],"enrollment":83,"completionDate":"2026-03-06"},{"nctId":"NCT07161505","phase":"NA","title":"Personalized Theta-burst Stimulation for Long-lasting Changes in Approach/Avoidance Behavior","status":"RECRUITING","sponsor":"Northwestern University","startDate":"2025-07-31","conditions":["Approach/Avoidance Behavior"],"enrollment":26,"completionDate":"2026-08-31"},{"nctId":"NCT04410900","phase":"PHASE1","title":"Vaccine Responsiveness After CAR-T Cell Therapy","status":"COMPLETED","sponsor":"Fred Hutchinson Cancer Center","startDate":"2020-08-03","conditions":["B-Cell Neoplasm"],"enrollment":49,"completionDate":"2025-08-31"},{"nctId":"NCT04961957","phase":"NA","title":"Waterproof Casting Versus Standard Casting for Short Leg Walking Casts","status":"WITHDRAWN","sponsor":"West Virginia University","startDate":"2025-09","conditions":["Ankle Fractures","Foot Fracture","Ankle Sprains","Foot Sprain","Toe-walking","Tendonitis of Foot","Apophysitis; Juvenile"],"enrollment":0,"completionDate":"2028-02"},{"nctId":"NCT06474026","phase":"NA","title":"A Clinical Trial to Evaluate the Safety and Efficacy of Neuromodulation Using 'ExAblate 4000 Type 2.1' in Patients With Psychostimulant Use Disorder(PUD)","status":"RECRUITING","sponsor":"Korea University Anam Hospital","startDate":"2024-07-01","conditions":["Psychostimulant Use Disorder(PUD)"],"enrollment":10,"completionDate":"2026-07-31"},{"nctId":"NCT03457948","phase":"PHASE2","title":"Pembrolizumab With Liver-Directed or Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors and Liver Metastases","status":"ACTIVE_NOT_RECRUITING","sponsor":"Nicholas Fidelman, MD","startDate":"2018-08-27","conditions":["Metastatic Malignant Neoplasm in the Liver","Neuroendocrine Neoplasm"],"enrollment":32,"completionDate":"2026-05-31"},{"nctId":"NCT07148622","phase":"NA","title":"Effects of Different Antibiotic Regimens in Preterm Premature Rupture of Membranes","status":"COMPLETED","sponsor":"Yuzuncu Yil University","startDate":"2024-10-01","conditions":["Preterm Premature Rupture of Membranes (PPROM)","Prophylaxis","Perinatal Outcomes"],"enrollment":40,"completionDate":"2025-08-10"},{"nctId":"NCT05343312","phase":"PHASE4","title":"In Vivo Efficacy of Artemether-Lumefantrine, Amodiaquine-Artesunate, Dihydroartemisinin-Piperaquine, and Pironaridine-Artesunate in Mozambique","status":"COMPLETED","sponsor":"Centro de Investigacao em Saude de Manhica","startDate":"2022-03-16","conditions":["Malaria"],"enrollment":870,"completionDate":"2025-07-30"},{"nctId":"NCT06670976","phase":"PHASE1","title":"Propranolol Plus Standard Radiation Therapy Before Surgery for the Treatment of Patients With Soft Tissue Sarcoma","status":"WITHDRAWN","sponsor":"Roswell Park Cancer Institute","startDate":"2026-05-15","conditions":["Soft Tissue Sarcoma"],"enrollment":0,"completionDate":"2029-11-15"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"route":"Oral","formulation":"Tablet","formulations":[{"form":"TABLET","route":"ORAL","productName":""}]},"crossReferences":{"UNII":"ETJ7Z6XBU4","SPL_ID":"ca7bbcc8-2354-375c-e053-2995a90a72a0","chemblId":"CHEMBL91"},"formularyStatus":[],"_enricherVersion":"v2-openfda","developmentCodes":[],"ownershipHistory":[{"period":"2013-","companyName":"Unique","relationship":"Original Developer"}],"publicationCount":20626,"therapeuticAreas":["Other"],"applicationNumber":"ANDA077829","biosimilarFilings":[],"originalDeveloper":"Unique","recentPublications":[{"date":"2026 Mar 30","pmid":"41913073","title":"Mapping opioid exposure through prescription data and postmortem analysis of opioid drugs in multiple tissues.","journal":"British journal of clinical pharmacology"},{"date":"2026 Mar 30","pmid":"41912508","title":"Expansion of Antarctic surface melt through the 21st century.","journal":"Nature communications"},{"date":"2026 Mar 30","pmid":"41912420","title":"Use of Low-Value Cancer Care in Practices Acquired by Private Equity Firms.","journal":"Journal of the National Cancer Institute"},{"date":"2026 Mar 29","pmid":"41911655","title":"Hydrological mechanisms and vegetation-soil moisture decoupling in restored alpine grasslands of the Qinghai-Tibet Plateau mining areas.","journal":"Journal of environmental management"},{"date":"2026 Mar 30","pmid":"41911506","title":"Directed Evolution of Glutamate Dehydrogenase for Oxaloacetate Amination and Biosynthesis of Aspartate-Derived Chemicals.","journal":"ACS synthetic biology"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"Unique","companyId":"unique","modality":"Small molecule","firstApprovalDate":"2013","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2006-03-29T00:00:00.000Z","mah":"SLATE RUN PHARMA","brand_name_local":null,"application_number":"ANDA077208"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2015-11-12T00:00:00.000Z","mah":"BAYER HEALTHCARE LLC","brand_name_local":null,"application_number":"NDA022015"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2022-11-16T00:00:00.000Z","mah":"CONCORD BIOTECH LTD","brand_name_local":null,"application_number":"ANDA210181"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2023-07-28T00:00:00.000Z","mah":"AMNEAL","brand_name_local":null,"application_number":"ANDA211212"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2025-09-23T00:00:00.000Z","mah":"GENZYME CORP","brand_name_local":null,"application_number":"NDA022405"},{"country_code":"TR","regulator":"TITCK","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IN","regulator":"CDSCO","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TH","regulator":"FDA-TH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"MY","regulator":"NPRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"PH","regulator":"FDA-PH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"CO","regulator":"INVIMA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"ZA","regulator":"SAHPRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"TW","regulator":"TFDA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"HK","regulator":"DH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":"UNIQUE","brand_name_local":null,"application_number":""},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"BR","regulator":"ANVISA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"MX","regulator":"COFEPRIS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AR","regulator":"ANMAT","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":2,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:09:26.976094+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}